| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -9.68 M USD | -9.57 M USD | -7.38 M USD | -3.36 M USD | -11.30 M USD | -498618 USD |
| Depreciation & Amortization | 970117 USD | 974355 USD | 814481 USD | 0 USD | — | — |
| Stock-Based Compensation | 238045 USD | 230496 USD | 260000 USD | — | — | — |
| Capital Expenditures | 231838 USD | 5368 USD | — | — | — | — |
| Cash Flow from Investing | -231838 USD | -221426 USD | -694142 USD | -880221 USD | — | -14000 USD |
| Cash Flow from Financing | 4.60 M USD | 14.56 M USD | 1.44 M USD | — | 23.40 M USD | 733862 USD |
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
| Free Cash Flow | -9.91 M USD | -9.58 M USD | — | — | — | — |
Intelligent Bio Solutions Inc. is a medical technology company specializing in intelligent, rapid, non-invasive testing solutions. Its primary offering, the Intelligent Fingerprinting Drug Testing Solution, utilizes fingerprint sweat analysis to detect recent use of common workplace drugs such as opiates, cocaine, methamphetamine, cannabis, benzodiazepines, and marijuana. This portable, hygienic, and cost-effective system enables sample collection in seconds and delivers results in under ten minutes, making it ideal for safety-critical environments. The company serves diverse industries including construction, mining, manufacturing, engineering, transport, logistics, drug treatment, law enforcement, and forensics, with accounts spanning multiple countries. Additionally, Intelligent Bio Solutions Inc. develops a Saliva Glucose Biosensor Platform aimed at real-time monitoring and diagnostic tests for chronic disease management. Operating through segments like Intelligent Fingerprinting Products and the biosensor platform, it focuses on advancing portable drug screening and biosensor technologies across regions including the United Kingdom, Asia Pacific, Americas, and rest of world. Founded in 2016 and headquartered in New York, New York, the company plays a key role in the growing market for non-invasive medical diagnostics.